Skip to Main Content

Paper Details

MECP2 Is a Frequently Amplified Oncogene with a Novel Epigenetic Mechanism That Mimics the Role of Activated RAS in Malignancy.
Cancer Discov
44
2016
-addicted cell, 5-hydroxymethylcytosine, Amplified, CpG, G12C, KRAS, KRAS(G12C)-addicted cell line, MAPK, MECP2, Malignancy, Oncogene, PI3K, RAS, RAS family, RAS family member, X-chromosome, cancer, cancer cell lines, cancers, human, malignancies, methyl cytosine-guanine dinucleotide, methyl cytosine-guanine dinucleotide (CpG) binding protein 2, oncogene, unmutated genes
Author NameAffiliation
Aedin C CulhaneDana-Farber Cancer Institute, Harvard T.H. Chan School of Public Health
Aedin C CulhaneDana-Farber Cancer Institute, Harvard T.H. Chan School of Public Health
Steven E SchumacherDana-Farber Cancer Institute, Massachusetts. Broad Institute of Harvard and MIT
Rameen BeroukhimDana-Farber Cancer Institute, Harvard Medical School, Massachusetts. Broad Institute of Harvard and MIT
Marc VidalDana-Farber Cancer Institute, Massachusetts. Center for Cancer Systems Biology, Harvard Medical School
  • 1 - 5

Datasets

Release 1.2